Clinical Trials in Maryland

Showing 501-520 of 23,284 trials

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

NCT06447025

An open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of CTI-1601 enrolling adolescent and adult patients with FRDA who have participated in a prior clinical study of CTI-1601 as well as children (age 2 years and older), adolescents and adults with FRDA who have not participated in a prior clinical study of CTI-1601.

Friedreich Ataxia

Larimar Therapeutics, Inc.85 participantsStarted Jan 2024

Los Angeles, California, United States • Gainesville, Florida, United States • Tampa, Florida, United States +5 more locations

RECRUITINGPhase 217 miles

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

NCT06311227

This phase II trial tests how well venetoclax works in treating patients with hairy cell leukemia that has come back after a period of improvement (relapsed). Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival.

Recurrent Hairy Cell LeukemiaRecurrent Hairy Cell Leukemia Variant

National Cancer Institute (NCI)20 participantsStarted Dec 2024

Duarte, California, United States • Irvine, California, United States • Aventura, Florida, United States +18 more locations

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Find Trials by Condition in Maryland

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).